Abstract:This study illustrates that PTP1B induces disruption in endocytosis and apoptosis of VSMCs through the Rab5‐PDGFRβ pathway, suggesting a potential association with the heightened vulnerability of carotid plaques. Our results also present novel evidence supporting the potential use of PTP1B inhibitors in the treatment of vulnerable carotid plaques. Background Protein tyrosine phosphatase 1B (PTP1B) is a protein tyrosine phosphatase and modulates platelet‐derived growth factor (PDGF)/platelet‐derived growth factor receptor (PDGFR) signaling in vascular smooth muscle cells (VSMCs) via endocytosis. However, the related molecular pathways that participated in the interaction of endo‐lysosome and the trafficking of PDGFR are largely unknown. This study aims to determine the subcellular regulating mechanism of PTP1B to the endo‐lysosome degradation of PDGFR in atherosclerotic carotid plaques, thereby offering a potential therapeutic target for the stabilization of carotid plaques. Methods The immunohistochemical staining technique was employed to assess the expression levels of both PDGFR‐β and Caspase 3 in stable and vulnerable carotid plaques. Tunnel staining was utilized to quantify the apoptosis of carotid plaques. Live‐cell imaging was employed to observe endocytic motility, while cell apoptosis was evaluated through Propidium Iodide staining. In an in vivo experiment, ApoE−/− mice were administered a PTP1B inhibitor to investigate the impact of PTP1B on atherosclerosis. Results The heightened expression of PDGFR‐β correlates with apoptosis in patients with vulnerable carotid plaques. At the subcellular level of VSMCs, PDGFR‐β plays a pivotal role in sustaining a balanced endocytosis system motility, regulated by the expression of Rab5, a key regulator of endocytic motility. And PTP1B modulates PDGFR‐β signaling via Rab5‐mediated endocytosis. Additionally, disrupted endocytic motility influences the interplay between endosomes and lysosomes, which is crucial for controlling PDGFR‐β trafficking. Elevated PTP1B expression induces cellular apoptosis and impedes migration and proliferation of carotid VSMCs. Ultimately, mice with PTP1B deficiency exhibit a reduction in atherosclerosis. Conclusion Our results illustrate that PTP1B induces disruption in endocytosis and apoptosis of VSMCs through the Rab5‐PDGFRβ pathway, suggesting a potential association with the heightened vulnerability of carotid plaques.

PTPN14 aggravates neointimal hyperplasia via boosting PDGFRβ signaling in smooth muscle cells

Inhibition of Polycomb Repressor Complex 2 Ameliorates Neointimal Hyperplasia by Suppressing Trimethylation of H3K27 in Vascular Smooth Muscle Cells.

M 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia Via Activation of the P-Anxa2/stat3 Pathway

m6A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway

PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension

PTP1B Modulates Carotid Plaque Vulnerability in Atherosclerosis Through Rab5‐PDGFRβ‐Mediated Endocytosis Disruption and Apoptosis

Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation

Abstract 3142: Pik3c3 Safeguards Smooth Muscle Identity by Promoting Lysosome-mediated Yap1 Degradation

PDGFRβ Signalling Regulates Local Inflammation and Synergizes with Hypercholesterolaemia to Promote Atherosclerosis

Tudor-SN exacerbates pathological vascular remodeling by promoting the polyubiquitination of PTEN via NEDD4-1

PTPN2 Negatively Regulates Macrophage Inflammation in Atherosclerosis

P4HA2-induced prolyl hydroxylation of YAP1 restricts vascular smooth muscle cell proliferation and neointima formation

Endothelial PHACTR1 Promotes Endothelial Activation and Atherosclerosis by Repressing PPARγ Activity Under Disturbed Flow in Mice

Endothelial PHACTR1 Promotes Endothelial Activation and Atherosclerosis by Repressing PPAR & gamma; Activity Under Disturbed Flow in Mice

The role of 6-phosphogluconate dehydrogenase in vascular smooth muscle cell phenotypic switching and angioplasty-induced intimal hyperplasia

SMYD3–PARP16 axis accelerates unfolded protein response and mediates neointima formation

PI3Kγ (phosphoinositide 3-Kinase Γ) Regulates Vascular Smooth Muscle Cell Phenotypic Modulation and Neointimal Formation Through CREB (cyclic AMP-Response Element Binding Protein)/YAP (Yes-Associated Protein) Signaling.

USP14 deficiency inhibits neointima formation following vascular injury via degradation of Skp2 protein

The ADP Antagonist MRS2179 Regulates the Phenotype of Smooth Muscle Cells to Limit Intimal Hyperplasia

XBP 1-Deficiency Abrogates Neointimal Lesion of Injured Vessels Via Cross Talk with the PDGF Signaling.

Pathological Role of Phosphoglycerate Kinase 1 in Balloon Angioplasty-Induced Neointima Formation